BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Narimatsu Y, Büll C, Chen YH, Wandall HH, Yang Z, Clausen H. Genetic glycoengineering in mammalian cells. J Biol Chem 2021;296:100448. [PMID: 33617880 DOI: 10.1016/j.jbc.2021.100448] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Li Y, Wang M, Hong S. Live-Cell Glycocalyx Engineering. Chembiochem 2023;24:e202200707. [PMID: 36642971 DOI: 10.1002/cbic.202200707] [Reference Citation Analysis]
2 Sørensen DM, Büll C, Madsen TD, Lira-Navarrete E, Clausen TM, Clark AE, Garretson AF, Karlsson R, Pijnenborg JFA, Yin X, Miller RL, Chanda SK, Boltje TJ, Schjoldager KT, Vakhrushev SY, Halim A, Esko JD, Carlin AF, Hurtado-Guerrero R, Weigert R, Clausen H, Narimatsu Y. Identification of global inhibitors of cellular glycosylation. Nat Commun 2023;14:948. [PMID: 36804936 DOI: 10.1038/s41467-023-36598-7] [Reference Citation Analysis]
3 Park S, Chin-Hun Kuo J, Reesink HL, Paszek MJ. Recombinant mucin biotechnology and engineering. Adv Drug Deliv Rev 2023;193:114618. [PMID: 36375719 DOI: 10.1016/j.addr.2022.114618] [Reference Citation Analysis]
4 Zinn S, Vazquez-Lombardi R, Zimmermann C, Sapra P, Jermutus L, Christ D. Advances in antibody-based therapy in oncology. Nat Cancer 2023;4:165-80. [PMID: 36806801 DOI: 10.1038/s43018-023-00516-z] [Reference Citation Analysis]
5 Ouadhi S, López DMV, Mohideen FI, Kwan DH. Engineering the enzyme toolbox to tailor glycosylation in small molecule natural products and protein biologics. Protein Eng Des Sel 2023;36:gzac010. [PMID: 36444941 DOI: 10.1093/protein/gzac010] [Reference Citation Analysis]
6 Divya M, Prabhu SR, Satyamoorthy K, Saadi AV. Therapeutics through glycobiology: an approach for targeted elimination of malaria. Biologia (Bratisl) 2023;:1-5. [PMID: 36643690 DOI: 10.1007/s11756-023-01312-x] [Reference Citation Analysis]
7 Hayes AJ, Melrose J. HS, an Ancient Molecular Recognition and Information Storage Glycosaminoglycan, Equips HS-Proteoglycans with Diverse Matrix and Cell-Interactive Properties Operative in Tissue Development and Tissue Function in Health and Disease. Int J Mol Sci 2023;24. [PMID: 36674659 DOI: 10.3390/ijms24021148] [Reference Citation Analysis]
8 Chen YH, Tian W, Yasuda M, Ye Z, Song M, Mandel U, Kristensen C, Povolo L, Marques ARA, Čaval T, Heck AJR, Sampaio JL, Johannes L, Tsukimura T, Desnick R, Vakhrushev SY, Yang Z, Clausen H. A universal GlycoDesign for lysosomal replacement enzymes to improve circulation time and biodistribution. Front Bioeng Biotechnol 2023;11:1128371. [PMID: 36911201 DOI: 10.3389/fbioe.2023.1128371] [Reference Citation Analysis]
9 Verhallen L, Lackman JJ, Wendt R, Gustavsson M, Yang Z, Narimatsu Y, Sørensen DM, Lafferty KM, Gouwy M, Marques PE, Hjortø GM, Rosenkilde MM, Proost P, Goth CK. "Glyco-sulfo barcodes" regulate chemokine receptor function. Cell Mol Life Sci 2023;80:55. [PMID: 36729338 DOI: 10.1007/s00018-023-04697-9] [Reference Citation Analysis]
10 Zhong X, Schenk J, Sakorafas P, Chamberland J, Tam A, Thomas LM, Yan G, D' Antona AM, Lin L, Nocula-Lugowska M, Zhang Y, Sousa E, Cohen J, Gu L, Abel M, Donahue J, Lim S, Meade C, Zhou J, Riegel L, Birch A, Fennell BJ, Franklin E, Gomes JM, Tzvetkova B, Scarcelli JJ. Impacts of fast production of afucosylated antibodies and Fc mutants in ExpiCHO-S™ for enhancing FcγRIIIa binding and NK cell activation. J Biotechnol 2022;360:79-91. [PMID: 36341973 DOI: 10.1016/j.jbiotec.2022.10.016] [Reference Citation Analysis]
11 Lau LS, Mohammed NBB, Dimitroff CJ. Decoding Strategies to Evade Immunoregulators Galectin-1, -3, and -9 and Their Ligands as Novel Therapeutics in Cancer Immunotherapy. Int J Mol Sci 2022;23. [PMID: 36555198 DOI: 10.3390/ijms232415554] [Reference Citation Analysis]
12 Hirata T, Harada Y, Hirosawa KM, Tokoro Y, Suzuki KGN, Kizuka Y. N-acetylglucosaminyltransferase-V (GnT-V)-enriched small extracellular vesicles mediate N-glycan remodeling in recipient cells. iScience 2023;26:105747. [PMID: 36590176 DOI: 10.1016/j.isci.2022.105747] [Reference Citation Analysis]
13 Peixoto A, Miranda A, Santos LL, Ferreira JA. A roadmap for translational cancer glycoimmunology at single cell resolution. J Exp Clin Cancer Res 2022;41:143. [DOI: 10.1186/s13046-022-02335-z] [Reference Citation Analysis]
14 Prabhu A, Shanmugam D, Gadgil M. Engineering nucleotide sugar synthesis pathways for independent and simultaneous modulation of N-glycan galactosylation and fucosylation in CHO cells. Metab Eng 2022;74:61-71. [PMID: 36152932 DOI: 10.1016/j.ymben.2022.09.003] [Reference Citation Analysis]
15 Adams TM, Zhao P, Chapla D, Moremen KW, Wells L. Sequential in vitro enzymatic N-glycoprotein modification reveals site-specific rates of glycoenzyme processing. J Biol Chem 2022;:102474. [PMID: 36089065 DOI: 10.1016/j.jbc.2022.102474] [Reference Citation Analysis]
16 Hirata T, Yang J, Tomida S, Tokoro Y, Kinoshita T, Fujita M, Kizuka Y. ER entry pathway and glycosylation of GPI-anchored proteins are determined by N-terminal signal sequence and C-terminal GPI-attachment sequence. J Biol Chem 2022;:102444. [PMID: 36055406 DOI: 10.1016/j.jbc.2022.102444] [Reference Citation Analysis]
17 Bojar D, Lisacek F. Glycoinformatics in the Artificial Intelligence Era. Chem Rev 2022. [PMID: 35961636 DOI: 10.1021/acs.chemrev.2c00110] [Reference Citation Analysis]
18 Adams TM, Zhao P, Chapla D, Moremen KW, Wells L. Sequential in vitro enzymatic N-glycoprotein modification reveals site-specific rates of glycoenzyme processing.. [DOI: 10.1101/2022.07.27.501726] [Reference Citation Analysis]
19 Dworkin LA, Clausen H, Joshi HJ. Applying transcriptomics to studyglycosylation at the cell type level. iScience 2022;25:104419. [PMID: 35663018 DOI: 10.1016/j.isci.2022.104419] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Kelkar A, Groth T, Neelamegham S. Forward Genetic Screens of Human Glycosylation Pathways Using the GlycoGene CRISPR Library. Curr Protoc 2022;2:e402. [PMID: 35427438 DOI: 10.1002/cpz1.402] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Dammen-brower K, Epler P, Zhu S, Bernstein ZJ, Stabach PR, Braddock DT, Spangler JB, Yarema KJ. Strategies for Glycoengineering Therapeutic Proteins. Front Chem 2022;10:863118. [DOI: 10.3389/fchem.2022.863118] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
22 de Haan N, Narimatsu Y, Koed Møller Aasted M, Larsen ISB, Marinova IN, Dabelsteen S, Vakhrushev SY, Wandall HH. In-Depth Profiling of O-Glycan Isomers in Human Cells Using C18 Nanoliquid Chromatography-Mass Spectrometry and Glycogenomics. Anal Chem 2022. [PMID: 35245040 DOI: 10.1021/acs.analchem.1c05068] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
23 Konstantinidi A, Nason R, Čaval T, Sun L, Sørensen DM, Furukawa S, Ye Z, Vincentelli R, Narimatsu Y, Vakhrushev SY, Clausen H. Exploring the glycosylation of mucins by use of O-glycodomain reporters recombinantly expressed in glycoengineered HEK293 cells. J Biol Chem 2022;:101784. [PMID: 35247390 DOI: 10.1016/j.jbc.2022.101784] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
24 Zhong X, D’antona AM, Scarcelli JJ, Rouse JC. New Opportunities in Glycan Engineering for Therapeutic Proteins. Antibodies 2022;11:5. [DOI: 10.3390/antib11010005] [Reference Citation Analysis]
25 van Houtum EJH, Büll C, Cornelissen LAM, Adema GJ. Siglec Signaling in the Tumor Microenvironment. Front Immunol 2021;12:790317. [PMID: 34966391 DOI: 10.3389/fimmu.2021.790317] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
26 Wu ZY, He YQ, Wang TM, Yang DW, Li DH, Deng CM, Cao LJ, Zhang JB, Xue WQ, Jia WH. Glycogenes in Oncofetal Chondroitin Sulfate Biosynthesis are Differently Expressed and Correlated With Immune Response in Placenta and Colorectal Cancer. Front Cell Dev Biol 2021;9:763875. [PMID: 34966741 DOI: 10.3389/fcell.2021.763875] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
27 Sun L, Konstantinidi A, Ye Z, Nason R, Zhang Y, Büll C, Kahl-Knutson B, Hansen L, Leffler H, Vakhrushev SY, Yang Z, Clausen H, Narimatsu Y. Installation of O-glycan sulfation capacities in human HEK293 cells for display of sulfated mucins. J Biol Chem 2021;:101382. [PMID: 34954141 DOI: 10.1016/j.jbc.2021.101382] [Reference Citation Analysis]
28 Yang G, Wang Q, Chen L, Betenbaugh MJ, Zhang H. Glycoproteomic Characterization of FUT8 Knock-Out CHO Cells Reveals Roles of FUT8 in the Glycosylation. Front Chem 2021;9:755238. [PMID: 34778211 DOI: 10.3389/fchem.2021.755238] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
29 Rangel-Angarita V, Malaker SA. Mucinomics as the Next Frontier of Mass Spectrometry. ACS Chem Biol 2021;16:1866-83. [PMID: 34319686 DOI: 10.1021/acschembio.1c00384] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
30 Gabius HJ, Cudic M, Diercks T, Kaltner H, Kopitz J, Mayo KH, Murphy PV, Oscarson S, Roy R, Schedlbauer A, Toegel S, Romero A. What is the Sugar Code? Chembiochem 2021. [PMID: 34496130 DOI: 10.1002/cbic.202100327] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
31 Bwanali L, Holland LA. Capillary Nanogel Electrophoresis for the Determination of the β1-4 Galactosyltransferase Michaelis-Menten Constant and Real-Time Addition of Galactose Residues to N-Glycans and Glycoprotein. Anal Chem 2021;93:11843-51. [PMID: 34410102 DOI: 10.1021/acs.analchem.1c02576] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
32 Hart DA. What Molecular Recognition Systems Do Mesenchymal Stem Cells/Medicinal Signaling Cells (MSC) Use to Facilitate Cell-Cell and Cell Matrix Interactions? A Review of Evidence and Options. Int J Mol Sci 2021;22:8637. [PMID: 34445341 DOI: 10.3390/ijms22168637] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
33 Nason R, Büll C, Konstantinidi A, Sun L, Ye Z, Halim A, Du W, Sørensen DM, Durbesson F, Furukawa S, Mandel U, Joshi HJ, Dworkin LA, Hansen L, David L, Iverson TM, Bensing BA, Sullam PM, Varki A, Vries E, de Haan CAM, Vincentelli R, Henrissat B, Vakhrushev SY, Clausen H, Narimatsu Y. Display of the human mucinome with defined O-glycans by gene engineered cells. Nat Commun 2021;12:4070. [PMID: 34210959 DOI: 10.1038/s41467-021-24366-4] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 16.0] [Reference Citation Analysis]
34 Visser EA, Moons SJ, Timmermans SBPE, de Jong H, Boltje TJ, Büll C. Sialic acid O-acetylation: From biosynthesis to roles in health and disease. J Biol Chem 2021;297:100906. [PMID: 34157283 DOI: 10.1016/j.jbc.2021.100906] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
35 Kinoshita M, Nakajima K, Yamamoto S, Suzuki S. High-throughput N-glycan screening method for therapeutic antibodies using a microchip-based DNA analyzer: a promising methodology for monitoring monoclonal antibody N-glycosylation. Anal Bioanal Chem 2021;413:4727-38. [PMID: 34080034 DOI: 10.1007/s00216-021-03434-0] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Gonzalez-Gil A, Schnaar RL. Siglec Ligands. Cells 2021;10:1260. [PMID: 34065256 DOI: 10.3390/cells10051260] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 11.5] [Reference Citation Analysis]
37 Büll C, Nason R, Sun L, Van Coillie J, Madriz Sørensen D, Moons SJ, Yang Z, Arbitman S, Fernandes SM, Furukawa S, McBride R, Nycholat CM, Adema GJ, Paulson JC, Schnaar RL, Boltje TJ, Clausen H, Narimatsu Y. Probing the binding specificities of human Siglecs by cell-based glycan arrays. Proc Natl Acad Sci U S A 2021;118:e2026102118. [PMID: 33893239 DOI: 10.1073/pnas.2026102118] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 18.5] [Reference Citation Analysis]